期刊文献+

前列腺素受体EP2在溃疡性结肠炎黏膜中的表达及临床意义 被引量:5

Expression and clinical significance of EP2 prostanoid receptor in colon mucosa of ulcerative colitis
原文传递
导出
摘要 目的通过检测溃疡性结肠炎(UC)结肠黏膜前列腺素EP2受体的表达,探讨EP2受体与UC黏膜炎症的关系。方法选取27例活动期UC、11例缓解期UC及23例正常对照者为研究对象。首先对UC患者按Souther-land疾病活动指数(UCAI)进行疾病分期及病理学分级,再进行免疫组化检测每例结肠上皮EP2的表达。结果免疫组化表明,活动期UC患者结肠上皮和炎症细胞中EP2的表达均高于UC缓解期及正常结肠黏膜(P<0.01),活动期UC患者EP2的表达与病理分级呈正相关。结论 EP2蛋白在活动期UC患者中的表达显著上调,且与炎症程度相关,EP2有可能作为UC治疗的新靶标。 Objective To explore the relationship between EP2 and ulcerative colitis(UC) by detecting the expression of EP2 in mucosa of UC.Methods 27 patients with active UC,11 patients with remissive UC and 23 normal control subjects were recruited into the trial.The ulcerative colitis disease activity index(UCAI) was used to calculate the pathological grade and disease stage.Expressions of EP2 were detected by the immunohistochemistry in colonic tissues of the patients and controls.Results The EP2 protein levels in colonic epithelial and inflammatory cells in the patients with active UC were higher compared with the patients with remissive UC and controls(P0.01).In the patients with active UC,EP2 expressions were positively related to the pathological grade.Conclusion Expressions of EP2 were significantly up regulated in the colon mucosa of active UC patients and positively correlated with the inflammation degree,which indicates EP2 may be a new target for the UC treatment.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第11期79-83,共5页 Journal of Shandong University:Health Sciences
关键词 溃疡性结肠炎 前列腺素受体EP2 免疫组织化学 Ulcerative colitis EP2 receptor Immunohistochemistry
  • 相关文献

参考文献23

  • 1Fujino H, Chen X B, Regan J W, et al. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells [J]. Biochem Biophys Res Commun, 2007, 359(3) :568-573.
  • 2中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1033
  • 3Schroeder K W, Tremaine W J, Ilstrup D M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately ac- tive ulcerative colitis: a randomized study [J]. N Engl J Med, 1987, 317 (26) :1625-1629.
  • 4Turelove S C, Richards W C. Biopsy studies in ulcerative colitis[J].BrMedJ, 1956, 1(4979) :1315-1318.
  • 5Koga H, Sakisaka S, Ohishi M, et al. Expression of cy- clooxygenase-2 in human hepatocellular carcinoma: rele- vance to tumor dedifferentiation[J].Hepotology, 1999, 29(3) :688-696.
  • 6Gupta R B, Harpaz N, Itzkowitz S, et al. Histologic in- flammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study[J]. Gastro- enterology, 2007, 133 (4) : 1099-1105.
  • 7Trivedi P P, Jena G B. Dextran sulfate sodium-induced ulcerative colitis leads to increased hematopoiesis and in- duces both local as well as systemic genotoxicity in mice [J]. Mutat Res, 2012, 744(2) :172-183.
  • 8Inada T, Arai K, Kawamura M, et al. Contribution of the prostaglandin E2/E-prostanoid 2 receptor signaling pathway in abscess formation in rat zymosan-induced pleurisy [J]. J Pharmacol Exp Ther, 2009, 331 ( 3 ) :860- 870.
  • 9Zahner G, Schaper M, Panzer U, et al. Prostaglandin EP2 and EP4 receptors modulate expression of the chemo- kine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation [ J ]. Biochem J, 2009, 422 (3) :563-570.
  • 10Benyahia C, Gomez I, Kanyinda L, et al. PGE2 recep- tor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy? [J]. Pulm Pharmacol Ther, 2012, 25(1) :115-118.

二级参考文献25

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献1048

同被引文献118

引证文献5

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部